معرفی
Dr. Daniel Hoyle is a Senior Lecturer in Therapeutics and Pharmacy Practice at the University of Tasmania's School of Pharmacy and Pharmacology. He holds a PhD in clinical outcomes of psychotropic reduction in aged care (2020) and has pioneered work on deprescribing strategies for older adults. His academic roles include unit coordination for fourth-year therapeutics in the pharmacy program and acting course coordinator for a fast-track pharmacy degree.
- Education: PhD (2020), BPharm(Hons) (2012)
- Research Focus: Medication management in elderly populations, psychotropic reduction in aged care facilities, deprescribing models, and clinical pharmacology.
- Grants: Lead investigator on the Geriatric Antipsychotic Stewardship (GApS) Program and anticholinergic medication alert systems for elderly patients.
His research emphasizes improving medication safety through projects like the RedUSe initiative, which reduced sedative use in 150 Australian aged care facilities. He also advises on consultancy and education through media collaborations and professional networks like the Australian Deprescribing Network.
Publications highlight clinical impacts of antipsychotic reduction, socioecological models for deprescribing, and physical restraint practices in elderly care. His work aligns with UN Sustainable Development Goal 3 (Good Health and Well-Being).
